These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 34572787)

  • 1. Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis.
    De Blander H; Morel AP; Senaratne AP; Ouzounova M; Puisieux A
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming.
    von Joest M; Chen C; Douché T; Chantrel J; Chiche A; Gianetto QG; Matondo M; Li H
    Cell Rep; 2022 Jul; 40(2):111074. PubMed ID: 35830812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence: a double-edged sword in cancer therapy.
    Xiao S; Qin D; Hou X; Tian L; Yu Y; Zhang R; Lyu H; Guo D; Chen XZ; Zhou C; Tang J
    Front Oncol; 2023; 13():1189015. PubMed ID: 37771436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
    Lau L; David G
    Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
    [No Abstract]   [Full Text] [Related]  

  • 6. Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role.
    Lau L; Porciuncula A; Yu A; Iwakura Y; David G
    Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SASP: Tumor Suppressor or Promoter? Yes!
    Rao SG; Jackson JG
    Trends Cancer; 2016 Nov; 2(11):676-687. PubMed ID: 28741506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
    Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
    J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To clear, or not to clear (senescent cells)? That is the question.
    Lujambio A
    Bioessays; 2016 Jul; 38 Suppl 1():S56-64. PubMed ID: 27417123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.
    Wang WJ; Cai GY; Chen XM
    Oncotarget; 2017 Sep; 8(38):64520-64533. PubMed ID: 28969091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition.
    Pan Y; Gu Z; Lyu Y; Yang Y; Chung M; Pan X; Cai S
    Rejuvenation Res; 2022 Aug; 25(4):160-172. PubMed ID: 35658548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Social Life" of Senescent Cells: What Is SASP and Why Study It?
    Borodkina AV; Deryabin PI; Giukova AA; Nikolsky NN
    Acta Naturae; 2018; 10(1):4-14. PubMed ID: 29713514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
    Ohtani N
    Inflamm Regen; 2022 Apr; 42(1):11. PubMed ID: 35365245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
    Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
    J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-induced senescence promotes breast cancer cells plasticity by inducing Lipocalin-2 expression.
    Morales-Valencia J; Lau L; Martí-Nin T; Ozerdem U; David G
    Oncogene; 2022 Sep; 41(38):4361-4370. PubMed ID: 35953598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
    Ritschka B; Storer M; Mas A; Heinzmann F; Ortells MC; Morton JP; Sansom OJ; Zender L; Keyes WM
    Genes Dev; 2017 Jan; 31(2):172-183. PubMed ID: 28143833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype.
    Kumari R; Jat P
    Front Cell Dev Biol; 2021; 9():645593. PubMed ID: 33855023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.